Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 11136 record(s)

Req # A-2022-001452

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-075408-992, Deputy Ministerial Meeting with DNAStack.

Organization: Health Canada

3 page(s)
May 2024

Req # A-2022-001617

Adverse Drug Reaction (ADR). Report number: 001025337

Organization: Health Canada

2 page(s)
May 2024

Req # A-2023-000321

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-102577-832.

Organization: Health Canada

104 page(s)
May 2024

Req # A-2023-000751

Adverse Drug Reactions (ADRs) for ONDANSETRON. Report numbers: 001043963, E2B_06419945, E2B_06428933, E2B_06445688. ADRs for PANTOPRAZOLE SODIUM. Report numbers: E2B_06417696, E2B_06464904, E2B_06416475. ADR for GUANFACINE. Report number: E2B_06450662.

Organization: Health Canada

670 page(s)
May 2024

Req # A-2023-000805

Adverse Drug Reactions (ADRs). Report numbers: 001045530, 001043774, E2B_06420188, 001053868.

Organization: Health Canada

157 page(s)
May 2024

Req # A-2023-000995

Adverse Drug Reactions (ADRs). Report numbers: E2B_06550581, 001054745.

Organization: Health Canada

25 page(s)
May 2024

Req # A-2023-001206

Adverse Drug Reactions (ADRs) for Pantoprazole sodium. Report numbers: ADRs for VYVANSE. Report numbers: E2B_06689079, E2B_06694353, 001068087.

Organization: Health Canada

1535 page(s)
May 2024

Req # A-2023-001226

Adverse Drug Reactions (ADRs). Report numbers: E2B_01988984, 001054277, E2B_03485164, E2B_06590137, E2B_06120205, E2B_06683023, E2B_05985220, E2B_06254412, E2B_04874558, 001041820.

Organization: Health Canada

215 page(s)
May 2024

Req # A-2023-001237

Adverse Drug Reactions (ADRs). Report numbers: 001065282, E2B_06680009, E2B_06683870, 001066811, E2B_03444012, E2B_06672027, 001048670, E2B_06696318, E2B_06677135, E2B_06642890.

Organization: Health Canada

407 page(s)
May 2024

Req # A-2023-001313

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-105061-143.

Organization: Health Canada

22 page(s)
May 2024
Date modified: